Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 210

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 210
---
 providing for benefits upon termination of employment. Executive Committee The Executive Committee is chaired by the Chief Executive Officer. Three new members joine d the Executive Committee in 2024: François Roger (Executive Vice President, Chief Financial Officer), Audrey Duval (Executive Vice President, Corporate Affairs), and Brian Foard (Executive Vice President, Specialty Care). As of February 13, 2025, the Executive Committee had 13 members, four of whom are women. In accordance with our Board Charter, the Board of Directors – in liaison with the Compensation Committee and the Appointments, Governance and CSR Committee, and on a proposal from the Chief Executive Officer – has established a policy on gender representation within Sanofi's executive bodies. A key objective of this policy is to support the creation of a talent pool of both women and men who can potentially join the Executive Committee in future.

| SANOFIFORM 20-F2024 | 121 |

| PART I                                             |
| ITEM 6. Directors, Senior Management and Employees |

Paul Hudson Chief Executive Officer Date of birth: October 14, 1967. Paul Hudson joined Sanofi as Chief Executive Officer on September 1, 2019. Previously CEO of Novartis Pharmaceuticals (2016-2019), where he was a member of the Executive Committee, Paul has had an extensive international career in healthcare that spans the US, Japan and Europe. Prior to Novartis, he worked for AstraZeneca, where he held several increasingly senior positions and most recently carried out the roles of President, AstraZeneca United States and Executive Vice President, North America. He began his career in sales and marketing roles at GlaxoSmithKline UK and Sanofi-Synthélabo UK. Paul holds a degree in economics from Manchester Metropolitan University in the UK and in 2018, his alma mater awarded him an honorary Doctor of Business Administration for his achievements in industry. He also holds a diploma in marketing from the Chartered Institute of Marketing, also in the UK. Paul Hudson is a citizen of the United Kingdom. Houman Ashrafian Executive Vice President, Head of Research and Development Date of birth: February 4, 1975. Houman Ashrafian joined Sanofi on September 11, 2023. Houman joined Sanofi from SV Health Investors where he was Managing Partner of the global private equity and venture capital investment platform which has a special focus on biotechnology, healthcare growth equity, and medtech. He has a robust track record in building